USPTO trademark

ADREPAN

RegisteredUSPTOWord markClass 5

"ADREPAN" is a word mark owned by Theravia, filed at the USPTO on October 3, 2023. It is registered and covers class 5 (Pharmaceuticals).

View Theravia portfolioGet this data via the API
Official USPTO record
ADREPAN trademark as filed
As filed with the USPTO
Status
Registered
Since August 13, 2024
Filed
October 3, 2023
Registered
August 13, 2024
Expires
Not recorded
Application no.
98207580
Registration no.
7475075
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ADREPAN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Theravia

Neuilly-Sur-Seine, France

6 trademarks in the portfolioView company

Representative

Christopher W. Brody

Millen, White, Zelano & Branigan, P.C.

Goods and services

What the mark covers

The products and services ADREPAN is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of sickle cell anemia; sanitary preparations for medical purposes; dietetic foods, namely, pasta, crackers, powders, bars adapted for medical use; dietetic sugar substitutes for medical use; all-purpose disinfectants for inhibiting the growth of bacteria; medical plasters, materials for dressings, namely, wadding and gauze, diagnostic preparations for medical purposes, chemical reagents for medical purposes, chemical reagents for medical or veterinary purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Teas change of correspondence received
  2. Teas change of domestic representatives address
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Teas change of correspondence received
  6. Teas change of domestic representatives address
  7. Attorney/dom.rep.revoked and/or appointed
  8. Teas revoke/app/change addr of atty/dom rep received
  9. Teas change of correspondence received
  10. Teas change of domestic representatives address

10 earlier steps on the official record.

FAQ

About ADREPAN

Who owns the trademark "ADREPAN"?

The USPTO trademark "ADREPAN" (application 98207580) is owned by Theravia.

What is the status of "ADREPAN"?

Its status at the USPTO is: registered.

When was "ADREPAN" registered?

It was registered on August 13, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ADREPAN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c27-fbc5-761f-91d3-0e7f29c27129
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c27-fbc5-761f-91d3-0e7f29c27129",
  "object": "trademark",
  "mark_text": "ADREPAN",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98207580",
  "filing_date": "2023-10-03",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "THERAVIA",
      "entity_id": "ent_019eb7e6-8136-771f-b7b5-45a56360c556"
    }
  ]
}